Evidence map›Paper›PMID 26140085›Full record

ReviewWorld journal of hepatology2015

Induced immunity against hepatitis B virus.

Zeinab Nabil Ahmed Said, Kouka Saadeldin Abdelwahab

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Eradication Strategies for Chronic Hepatitis B Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zeinab Nabil Ahmed SaidZeinab Nabil Ahmed Said, Kouka Saadeldin Abdelwahab, Department of Microbiology and Immunology, Faculty of Medicine (for girls), Al-Azhar University, Cairo 11754, Egypt.
Kouka Saadeldin AbdelwahabZeinab Nabil Ahmed Said, Kouka Saadeldin Abdelwahab, Department of Microbiology and Immunology, Faculty of Medicine (for girls), Al-Azhar University, Cairo 11754, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prevention of hepatitis B virus (HBV) infection with its consequent development of HBV chronic liver disease and hepatocellular carcinoma is a global mandatory goal. Fortunately, safe and effective HBV vaccines are currently available. Universal hepatitis B surface antigen HBV vaccination coverage is almost done. Growing knowledge based upon monitoring and surveillance of HBV vaccination programs has accumulated and the policy of booster vaccination has been evaluated. This review article provides an overview of the natural history of HBV infection, immune responses and the future of HBV infection. It also summarizes the updated sources, types and uses of HBV vaccines, whether in the preclinical phase or in the post-field vaccination.

Indexed as

Booster and therapeutic vaccinationHepatitis B surface antigenHepatitis B virusHepatitis B virus vaccinesImmunological memory

Identifiers

PMID26140085
PMCPMC4483547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.